Rituximab-induced acute thrombocytopenia in a patient with prolymphocytic leukemia.
Pamuk
Gülsüm Emel
GE
Donmez
Salim
S
Turgut
Burhan
B
Demir
Muzaffer
M
Vural
Ozden
O
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015463:Leukemia, Prolymphocytic / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab; D013921:Thrombocytopenia / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab